Empowering Patient Safety: Assessment of Adverse Drug Reaction Knowledge and Practice Among Pharmacy Professionals

Despite technological advancements, healthcare professionals must actively prioritize patient safety. Reporting adverse drug reactions is a critical aspect of this responsibility, and the most accessible healthcare providers, community pharmacists, and pharmacy technicians play a key role. Therefore...

Full description

Bibliographic Details
Published in:	Pharmacy
Main Authors:	Josipa Bukić, Dario Leskur, Toni Durdov, Joško Božić, Darko Modun, Ana Šešelja Perišin, Daniela Ančić, Martina Šepetavc, Ante Mihanović, Doris Rušić
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Subjects:	adverse drug reaction drug safety pharmacists pharmacovigilance
Online Access:	https://www.mdpi.com/2226-4787/13/1/1

Similar Items

Evaluating Pharmacists’ Knowledge of Food–Drug Interactions in Croatia: Identifying Gaps and Opportunities
by: Josipa Bukić, et al.
Published: (2024-11-01)

Teaching Pharmacovigilance to Healthcare Students: Identifying Gaps and Opportunities for Improvement
by: Ana Seselja Perisin, et al.
Published: (2021-08-01)

Future Healthcare Workers and Ecopharmacovigilance: Where Do We Stand?
by: Toni Durdov, et al.
Published: (2024-09-01)

Pharmacy Customers’ Attitudes Towards Expanded Pharmacy Services in Croatia
by: Josipa Bukic, et al.
Published: (2024-12-01)

Are We Making the Most of Community Pharmacies? Implementation of Antimicrobial Stewardship Measures in Community Pharmacies: A Narrative Review
by: Doris Rusic, et al.
Published: (2021-01-01)

Attitudes of Community Pharmacy Service Users towards Vaccination Programs in Pharmacy: A Cross-Sectional Survey-Based Study in Croatia
by: Doris Rusic, et al.
Published: (2022-12-01)

Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial
by: Doris Rusic, et al.
Published: (2024-12-01)

Efficacy and Safety Assessment of Topical Omega Fatty Acid Product in Experimental Model of Irritant Contact Dermatitis: Randomized Controlled Trial
by: Magdalena Ivic, et al.
Published: (2024-07-01)

Tackling the Antimicrobial Resistance “Pandemic” with Machine Learning Tools: A Summary of Available Evidence
by: Doris Rusic, et al.
Published: (2024-04-01)

Investigation of Biomedical Students’ Attitudes toward Pharmacogenomics and Personalized Medicine: A Cross-Sectional Study
by: Josipa Bukic, et al.
Published: (2022-06-01)

Reporting Quality of Randomized Controlled Trial Abstracts on Aesthetic Use of Botulinum Toxin: How Much Do Abstracts Actually Tell Us?
by: Ante Sucic, et al.
Published: (2023-08-01)

Semaglutide in the Real World: Attitudes of the Population
by: Doris Rušić, et al.
Published: (2025-09-01)

Did an introduction of CONSORT for abstracts guidelines improve reporting quality of randomised controlled trials’ abstracts on Helicobacter pylori infection? Observational study
by: Josipa Bukic, et al.
Published: (2022-03-01)

Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks
by: Doris Rusic, et al.
Published: (2021-03-01)

Young Women’s Attitudes and Behaviors in Treatment and Prevention of UTIs: Are Biomedical Students at an Advantage?
by: Ivan Jerkovic, et al.
Published: (2023-06-01)

Evaluation of Reporting Quality of Glaucoma Randomized Controlled Trial Abstracts: Current Status and Future Perspectives
by: Ana Vucinovic, et al.
Published: (2024-01-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait
by: Fatemah M. Alsaleh, et al.
Published: (2017-09-01)

Pharmacovigilance in Practice: Insights into Knowledge, Attitudes, and Practices of Pharmacists and Pharmacy Technicians in Saudi Arabia
by: Saeed Alshahrani, et al.
Published: (2025-04-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

Awareness of Digital Reporting of Adverse Drug Events among Health Care Professionals
by: Shweta Sharma, et al.
Published: (2023-09-01)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017-03-01)

Quality and readability of drug fact sheets for FDA-approved and emergency use authorised drug products for COVID-19 treatment: an observational study
by: Josipa Bukic, et al.
Published: (2025-10-01)

Pharmacists’ Experiences on Adverse Drug Reactions in Saudi Arabia: A Cross-Sectional Study
by: Dalal Salem Bakheit Aldossari, et al.
Published: (2025-06-01)

Improving ADR reporting in Jordan: a qualitative exploration of pharmacists’ perspectives
by: Amal K. Suleiman
Published: (2025-01-01)

Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey
by: Amani Khardali
Published: (2024-02-01)

Assessment of pharmacovigilance activities among pharmacist interns in Nigeria: a cross-sectional study
by: Shadrach Chinecherem Eze, et al.
Published: (2023-02-01)

Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa
by: M.C. Joubert, et al.
Published: (2016-12-01)

Knowledge, attitude, and practice among community pharmacists toward adverse drug reaction reporting and pharmacovigilance: A nationwide survey
by: Tahani Alwidyan, et al.
Published: (2025-06-01)

Role of the hospital pharmacists during COVID-19 pandemic in the RN Macedonia
by: Zorica Naumovska, et al.
Published: (2024-12-01)

Analysis of pharmacy organisation staff awareness of pharmacovigilance
by: R. I. Yagudina, et al.
Published: (2025-06-01)

Comparison of the Impact of Insulin Degludec U100 and Insulin Glargine U300 on Glycemic Variability and Oxidative Stress in Insulin-Naive Patients With Type 2 Diabetes Mellitus: Pilot Study for a Randomized Trial
by: Pavle Vrebalov Cindro, et al.
Published: (2022-07-01)

Educational intervention impact assessment on pharmacovigilance knowledge, attitude and practice among hospital pharmacy practitioners in Dubai
by: Sawsan Shanableh, et al.
Published: (2025-12-01)

Pharmacists' interventions in the population of pregnant women and recomandations for pharmacy practice impoveme
by: Odalović Marina, et al.
Published: (2015-01-01)

Hospital Pharmacists’ Perspectives on Adverse Drug Reaction Reporting in Developed and Developing Countries: A Comparative Pilot Study
by: Javeria Khalid, et al.
Published: (2025-07-01)

Spontaneous adverse drug reaction reporting: potential facilitators perceived by community pharmacists in Egypt – a cross-sectional study
by: Mohamed Bahlol, et al.
Published: (2025-09-01)

Understanding community pharmacists’ intentions to report adverse drug reactions in Saudi Arabia: a theory of planned behavior analysis
by: Fahad T. Alsulami, et al.
Published: (2025-05-01)

Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
by: Tanattha Kitisopee, et al.
Published: (2022-12-01)

Integrating pharmacovigilance into the routine of pharmacy department: experience of nine years
by: Ariadna Pérez-Ricart, et al.
Published: (2019-07-01)

Knowledge and Perception about Pharmacovigilance among Pharmacy Students of Universities in Sana’a Yemen
by: Gamil Qasem Othman, et al.
Published: (2017-06-01)